Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • For Subscribers
    • For Advertisers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • For Subscribers
    • For Advertisers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleBehavioral Pharmacology

Effects of Spinally Administered Bifunctional Nociceptin/Orphanin FQ Peptide Receptor/μ-Opioid Receptor Ligands in Mouse Models of Neuropathic and Inflammatory Pain

Devki D. Sukhtankar, Nurulain T. Zaveri, Stephen M. Husbands and Mei-Chuan Ko
Journal of Pharmacology and Experimental Therapeutics July 2013, 346 (1) 11-22; DOI: https://doi.org/10.1124/jpet.113.203984
Devki D. Sukhtankar
Department of Pharmacology, University of Michigan Medical School, Ann Arbor, Michigan (D.D.S.); Astraea Therapeutics, LLC, Mountain View, California (N.T.Z.); Department of Pharmacy and Pharmacology, University of Bath, Bath, United Kingdom (S.M.H.); and Department of Physiology and Pharmacology, Wake Forest University School of Medicine, Winston-Salem, North Carolina (M.-C.K.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nurulain T. Zaveri
Department of Pharmacology, University of Michigan Medical School, Ann Arbor, Michigan (D.D.S.); Astraea Therapeutics, LLC, Mountain View, California (N.T.Z.); Department of Pharmacy and Pharmacology, University of Bath, Bath, United Kingdom (S.M.H.); and Department of Physiology and Pharmacology, Wake Forest University School of Medicine, Winston-Salem, North Carolina (M.-C.K.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen M. Husbands
Department of Pharmacology, University of Michigan Medical School, Ann Arbor, Michigan (D.D.S.); Astraea Therapeutics, LLC, Mountain View, California (N.T.Z.); Department of Pharmacy and Pharmacology, University of Bath, Bath, United Kingdom (S.M.H.); and Department of Physiology and Pharmacology, Wake Forest University School of Medicine, Winston-Salem, North Carolina (M.-C.K.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mei-Chuan Ko
Department of Pharmacology, University of Michigan Medical School, Ann Arbor, Michigan (D.D.S.); Astraea Therapeutics, LLC, Mountain View, California (N.T.Z.); Department of Pharmacy and Pharmacology, University of Bath, Bath, United Kingdom (S.M.H.); and Department of Physiology and Pharmacology, Wake Forest University School of Medicine, Winston-Salem, North Carolina (M.-C.K.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading
Submit a Response to This Article
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 346 (1)
Journal of Pharmacology and Experimental Therapeutics
Vol. 346, Issue 1
1 Jul 2013
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Effects of Spinally Administered Bifunctional Nociceptin/Orphanin FQ Peptide Receptor/μ-Opioid Receptor Ligands in Mouse Models of Neuropathic and Inflammatory Pain
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
Citation Tools
Research ArticleBehavioral Pharmacology

Bifunctional NOP/MOP Ligands in Mouse Chronic Pain Models

Devki D. Sukhtankar, Nurulain T. Zaveri, Stephen M. Husbands and Mei-Chuan Ko
Journal of Pharmacology and Experimental Therapeutics July 1, 2013, 346 (1) 11-22; DOI: https://doi.org/10.1124/jpet.113.203984

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleBehavioral Pharmacology

Bifunctional NOP/MOP Ligands in Mouse Chronic Pain Models

Devki D. Sukhtankar, Nurulain T. Zaveri, Stephen M. Husbands and Mei-Chuan Ko
Journal of Pharmacology and Experimental Therapeutics July 1, 2013, 346 (1) 11-22; DOI: https://doi.org/10.1124/jpet.113.203984
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Authorship Contributions
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • The Neuropeptide Y Y2 receptor is co-expressed with Nppb in primary afferent neurons and Y2 activation reduces histaminergic and IL-31-induced itch
  • New D3R Antagonists Do Not Increase Hypertension
  • Nicotine as an Opioid Adjuvant
Show more Behavioral Pharmacology

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2019 by the American Society for Pharmacology and Experimental Therapeutics